BioMotiv is a therapeutic development company that accelerates discoveries into medicines through an innovative, mission-driven model that efficiently aligns collaborations and capital for the benefit of inventors, investors, physicians and patients.

Funding: University Hospitals, Harrington Family, Nationwide Medical Insurance, Takeda Pharmaceutical, Biogen

Stage: Preclinical

News: BioMotiv Announces New Startup Koutif Therapeutics,BioMotiv Announces Immuno-Oncology Startup with New Zealand University